MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Revenue
$20,874K
Net Income
-$69,160K
Net Profit Margin
-331.32%
EPS
-$0.77
Unit: Thousand (K) dollars
Revenue Breakdown
    • License And Collaboration Revenu...
    • Product
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
20,874
18,265
17,336
20,750
Cost of product sales
243
262
14*
-
Research and development
61,891
65,263
64,408
67,908
General and administrative
-
-
-
32,839
Selling, general and administrative
31,750
31,555
39,182*
-
Total operating expenses
93,884
97,080
103,604
100,747
Loss from operations
-73,010
-78,815
-86,268
-79,997
Interest and other income, net
5,033
5,826
5,686
6,274
Interest expense
345
336
346
393
Total other income, net
4,688
5,490
5,340
5,881
Loss before income taxes
-68,322
-73,325
-80,928
-74,116
Income tax expense
5
8
71
-
Net loss
-68,327
-73,333
-80,999
-74,116
Unrealized gain on short-term investments
-
-
260
-
Unrealized loss on short-term investments
-833
-1,404
-
-
Comprehensive loss
-69,160
-74,737
-80,739
-
Basic EPS
-0.77
-0.83
-0.917
-0.85
Diluted EPS
-0.77
-0.83
-0.917
-0.85
Basic Average Shares
88,855,000
88,610,000
88,058,000
87,645,000
Diluted Average Shares
88,855,000
88,610,000
88,058,000
87,645,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

KURA Income Statement Sankey DiagramSankey diagram visualizing KURA income statement for the periodComprehensive loss-$69,160K Net loss-$68,327K (-3.33%↓ Y/Y)Unrealized loss onshort-term investments-$833K Interest and otherincome, net$5,033K (-27.43%↓ Y/Y)Loss before incometaxes-$68,322K (-3.33%↓ Y/Y)Income tax expense$5K Total other income,net$4,688K (-28.36%↓ Y/Y)License AndCollaboration Revenue$11,752K Product$9,122K Interest expense$345K (-11.76%↓ Y/Y)Loss from operations-$73,010K (-0.47%↓ Y/Y)Total revenue$20,874K (36.54%↑ Y/Y)Total operatingexpenses$93,884K (6.74%↑ Y/Y)Research and development$61,891K (-1.42%↓ Y/Y)Selling, general andadministrative$31,750K Cost of product sales$243K

Kura Oncology, Inc. (KURA)

Kura Oncology, Inc. (KURA)